NightstaRx
Develops gene therapies to cure retinal dystrophies
Total raised
€32M
€31,818,181
Funding rounds
1
Investors
1
distinct backers
Active since
2015-10
latest 2015-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood19
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-11-01 | Series B | €32M | New Enterprise Associates | View deal → |